Spero

SPRO NASDAQ
13.65
+0.21
+1.56%
Opening 10:26 06/25 EDT
Open
13.48
Prev Close
13.44
High
13.71
Low
13.48
Volume
2.18K
Avg Vol (3M)
68.11K
52 Week High
18.23
52 Week Low
5.52
% Turnover
0.01%
Market Cap
242.98M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Spero SPRO stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing novel treatments for MDR bacterial infections. The Company is developing a portfolio of novel product candidates, including SPR994, Potentiator Platform (SPR741 and SPR206), and SPR720. SPR994 is novel oral formulation of tebipenem, a carbapenem-class antibiotic. SPR994 is effective against a broad spectrum of MDR bacterial infections, its initial focus is on the treatment of cUTIs. Potentiator platform that enables to develop drugs that expand the spectrum and potency of existing antibiotics, including inactive antibiotics, against Gram-negative bacteria. SPR720 is novel oral therapy product candidate designed for the treatment of NTM, a rare lung infection often occurring in patients with compromised immune systems, including HIV, or respiratory conditions, such as cystic fibrosis, asthma and bronchiectasis.
MORE >

Recently

Name
Price
%Change